Mahalo | $2,600,000 | (Jun 26, 2025)
Elfie | $12,000,000 | (Jun 26, 2025)
AllSpice.io | $15,000,000 | (Jun 26, 2025)
Certified by Founder
Lodge
Clarametyx Biosciences
start up
United States
- Columbus, Ohio
- 08/01/2024
- Series A
- $33,000,000
Clarametyx Biosciences Inc. is a clinical stage biotechnology company developing immune-enabling biologic therapies to fight life-threatening infections. Our novel technology platform targets the protective barrier around bacteria, known as biofilms.
- Industry Biotechnology Research
- Website https://clarametyx.com/
- LinkedIn https://www.linkedin.com/company/clarametyx-biosciences/about/
Related People
David V. RichardsFounder
United States -
Columbus, Ohio
Life sciences executive and entrepreneur with a passion for building transformative science into compelling companies. Focus on high patient need categories that hold the potential for broad impact on national and global health, with a personal interest in infectious disease, neurocognitive and genetic disorders.
Pro Athlete Community (PAC) | $7,600,000 | (Jun 26, 2025)
Mandolin | $40,000,000 | (Jun 26, 2025)
Kalshi | $185,000,000 | (Jun 26, 2025)
PoliCloud | $8,794,146 | (Jun 26, 2025)
Armory | $1,511,654 | (Jun 26, 2025)
Obviant | $7,100,000 | (Jun 26, 2025)
Qunnect | $10,000,000 | (Jun 26, 2025)
Neuron23 | $96,500,000 | (Jun 26, 2025)
Blank Metal | $3,000,000 | (Jun 25, 2025)